Page 20 - IJB-9-3
P. 20
International Journal of Bioprinting Bioprinting of PDAC microtissues for drug screening
https://doi.org/10.18063/ijb.v7i4.444 https://doi.org/10.1186/s13046-019-1153-8
19. Antunes J, Gaspar VM, Ferreira L, et al., 2019, In-air 30. Rimal R, Desai P, Daware R, et al., 2022, Cancer-associated
production of 3D co-culture tumor spheroid hydrogels for fibroblasts: Origin, function, imaging, and therapeutic
expedited drug screening. Acta Biomater, 94: 392–409. targeting. Adv Drug Deliv Rev, 189: 114504.
https://doi.org/10.1016/j.actbio.2019.06.012 https://doi.org/10.1016/j.addr.2022.114504
20. Monteiro MV, Gaspar VM, Mendes L, et al., 2021, Stratified 31. Han CC, Liu TY, Yin R, 2020, Biomarkers for cancer-
3D microtumors as organotypic testing platforms for associated fibroblasts. Biomark Res, 8: 64.
screening pancreatic cancer therapies. Small Methods,
5: 2001207. https://doi.org/10.1186/s40364-020-00245-w
32. Lee JH, Kim SK, Khawar IA, et al., 2018, Microfluidic
https://doi.org/10.1002/smtd.202001207
co-culture of pancreatic tumor spheroids with stellate cells
21. Monteiro MV, Rocha M, Gaspar VM, et al., 2022, as a novel 3D model for investigation of stroma-mediated
Programmable living units for emulating pancreatic tumor- cell motility and drug resistance. J Exp Clin Canc Res, 37: 4.
stroma interplay. Adv Healthc Mater, 11: e2102574.
https://doi.org/10.1186/s13046-017-0654-6
https://doi.org/10.1002/adhm.202102574
33. Mehrpouya M, Pourhashem Z, Yardehnavi N, et al., 2019,
22. Murphy SV, De Coppi P, Atala A, 2020, Opportunities and Evaluation of cytokeratin 19 as a prognostic tumoral and
challenges of translational 3D bioprinting. Nat Biomed Eng, metastatic marker with focus on improved detection
4: 370–80. methods. J Cell Physiol, 234: 21425–21435.
https://doi.org/10.1038/s41551-019-0471-7 https://doi.org/10.1002/jcp.28768
23. Ayan B, Heo DN, Zhang Z, et al., 2020, Aspiration-assisted 34. Von Ahrens D, Bhagat TD, Nagrath D, et al., 2017, The role
bioprinting for precise positioning of biologics. Sci Adv, 6: of stromal cancer-associated fibroblasts in pancreatic cancer.
eaaw5111. J Hematol Oncol, 10: 76.
https://doi.org/10.1126/sciadv.aaw5111 https://doi.org/10.1186/s13045-017-0448-5
24. Matai I, Kaur G, Seyedsalehi A, et al., 2020, Progress in 35. Ligorio M, Sil S, Malagon-Lopez J, et al., 2019, Stromal
3D bioprinting technology for tissue/organ regenerative microenvironment shapes the intratumoral architecture of
engineering. Biomaterials, 226: 119536. pancreatic cancer. Cell, 178: 160–175.
https://doi.org/10.1016/j.biomaterials.2019.119536 https://doi.org/10.1016/j.cell.2019.05.012
25. Xie MJ, Gao Q, Zhao HM, et al., 2019, Electro-assisted 36. Ware MJ, Keshishian V, Law JJ, et al., 2016, Generation of an
bioprinting of low-concentration GelMA microdroplets. in vitro 3D PDAC stroma rich spheroid model. Biomaterials,
Small, 15: 1804216. 108: 129–142.
https://doi.org/10.1002/smll.201804216 https://doi.org/10.1016/j.biomaterials.2016.08.041
26. Clua-Ferré L, De Chiara F, Rodríguez-Comas J, et al., 2022, 37. Berlin J, Benson AB 3 , 2010, Gemcitabine remains the
rd
Collagen-tannic acid spheroids for β-cell encapsulation standard of care for pancreatic cancer. Nat Rev Clin Oncol,
fabricated using a 3D bioprinter. Adv Mater Technol-US, 7: 135–137.
7: 2101696.
https://doi.org/10.1038/nrclinonc.2010.16
https://doi.org/10.1002/admt.202101696
38. Liu HQ, Shi Y, Qian F, 2021, Opportunities and delusions
27. Vennin C, Murphy KJ, Morton JP, et al., 2018, Reshaping regarding drug delivery targeting pancreatic cancer-
the tumor stroma for treatment of pancreatic cancer. associated fibroblasts. Adv Drug Deliv Rev, 172: 37–51.
Gastroenterology, 154: 820–838.
https://doi.org/10.1016/j.addr.2021.02.012
https://doi.org/10.1053/j.gastro.2017.11.280
39. Benton G, Arnaoutova I, George J, et al., 2014, Matrigel:
28. Rubiano A, Delitto D, Han S, et al., 2018, Viscoelastic
properties of human pancreatic tumors and in vitro From discovery and ECM mimicry to assays and models for
constructs to mimic mechanical properties. Acta Biomater, cancer research. Adv Drug Deliv Rev, 79-80: 3–18.
67: 331–340. https://doi.org/10.1016/j.addr.2014.06.005
https://doi.org/10.1016/j.actbio.2017.11.037 40. Liu HY, Korc M, Lin CC, 2018, Biomimetic and enzyme-
responsive dynamic hydrogels for studying cell-matrix
29. Looi CK, Chung FF, Leong CO, et al., 2019, Therapeutic
challenges and current immunomodulatory strategies interactions in pancreatic ductal adenocarcinoma.
in targeting the immunosuppressive pancreatic tumor Biomaterials, 160: 24–36.
microenvironment. J Exp Clin Canc Res, 38: 162. https://doi.org/10.1016/j.biomaterials.2018.01.012
Volume 9 Issue 3 (2023) 12 https://doi.org/10.18063/ijb.v9i3.676

